The abnormal activation of GLI2 in HCC also interacts with other transcription factors, such as Wnt and TGF-β.These interactions further aggravate the malignant transformation of hepatocytes and the development of tumors by affecting the upstream or downstream regulatory mechanisms of GLI2. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.